EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass

Federica Moscucci iD, Francesco Baratta iD, Daniele Pastori iD, Danilo Menichelli iD, Anna Vittoria Mattioli iD, Sabina Gallina iD, Ilaria Lospinuso, Susanna Sciomer iD, Gianfranco Piccirillo iD, Giovambattista Desideri

Nutrients · 14.02.2026 · 18 (4) · 632

DOI: 10.3390/nu18040632 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 14.02.2026. Verfasst von Federica Moscucci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Unit, DAI of Internal Medicine and Medical Specialties, Azienda Ospedaliera Universitaria Policlinico Umberto I, Viale del Policlinico n.15…. Hauptthemen laut MEDLINE: Weight Loss, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity in women over 65 represents a growing clinical challenge, particularly due to its association with increased risks of cardiovascular disease, osteoarthritis, frailty, sleep-breathing disorders, and sarcopenia. The prevalence of obesity in this demographic is compounded by age-related metabolic changes and declining physical activity. In this context, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, have emerged as promising pharmacological treatments for weight loss, showing substantial efficacy in reducing body weight and improving metabolic health. However, their use in older populations warrants careful consideration due to the potential risk of muscle loss, which may exacerbate sarcopenia and frailty. This review synthesizes current evidence on the efficacy of GLP-1 RAs for weight loss in older women, exploring both the metabolic benefits and potential risks, particularly with regard to muscle mass preservation. We discuss the mechanisms behind muscle loss associated with GLP-1 RAs, focusing on the balance between fat reduction and the preservation of lean body mass. In phase 3 trials, women aged ≥ 65 years achieved sustained weight loss of 10–20%, with consistent cardiometabolic improvements. Furthermore, we propose practical strategies to mitigate sarcopenia, including physical activity interventions, dietary modifications, and combination therapies aimed at maintaining muscle strength while promoting weight loss. By examining clinical trial data, real-world evidence, and physiological mechanisms, this narrative review aims to provide a comprehensive framework for personalized and safe therapeutic decision-making, addressing the unique needs of older women with obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossGlucagon-Like Peptide-1 Receptor AgonistsObesityHumansFemaleSemaglutideAgedSarcopeniaTirzepatideGlucagon-Like PeptidesBody Composition

Stichwörter der Autor:innen

GLP-1 receptor agonistcardiovascular preventionlifestyle for preventionobesityold womensarcopenia prevention

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsSemaglutideTirzepatideGlucagon-Like Peptides

Autor:innen und Institutionen

  • Geriatric Unit, DAI of Internal Medicine and Medical Specialties, Azienda Ospedaliera Universitaria Policlinico Umberto I, Viale del Policlinico n.155, 00185 Rome, Italy.
  • Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Department of Medical and Cardiovascular Sciences, University of Rome "Sapienza", 00161 Rome, Italy.
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, 86077 Pozzilli, Italy.
  • Department of General Surgery, Surgical Specialty and Anesthesiology Paride Stefanini, Sapienza University of Rome, 00161 Rome, Italy.
  • Department of Quality of Life, University of Bologna-Alma Mater Studiorum, 40126 Bologna, Italy.

ORCID-Profile: Federica Moscucci, Francesco Baratta, Daniele Pastori, Danilo Menichelli, Anna Vittoria Mattioli, Sabina Gallina, Susanna Sciomer, Gianfranco Piccirillo

Zitieren

APA

Moscucci, F., Baratta, F., Pastori, D., Menichelli, D., Mattioli, A. V., Gallina, S., Lospinuso, I., Sciomer, S., Piccirillo, G., & Desideri, G. (2026). A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass. Nutrients, 18(4), 632. https://doi.org/10.3390/nu18040632

Vancouver

Moscucci F, Baratta F, Pastori D, Menichelli D, Mattioli AV, Gallina S, et al. A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass. Nutrients. 2026;18(4):632. doi:10.3390/nu18040632

BibTeX
@article{Moscucci2026,
  author = {Moscucci, Federica and Baratta, Francesco and Pastori, Daniele and Menichelli, Danilo and Mattioli, Anna Vittoria and Gallina, Sabina and Lospinuso, Ilaria and Sciomer, Susanna and Piccirillo, Gianfranco and Desideri, Giovambattista},
  title = {A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {632},
  doi = {10.3390/nu18040632}
}
Kostenlos starten →